453 related articles for article (PubMed ID: 17241440)
1. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients.
Campo J; Cano J; del Romero J; Hernando V; Rodríguez C; Bascones A
Oral Dis; 2007 Jan; 13(1):110-6. PubMed ID: 17241440
[TBL] [Abstract][Full Text] [Related]
2. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
5. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T
Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967
[TBL] [Abstract][Full Text] [Related]
7. Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients.
Bonamigo RR; Borges K; Rietjens J; Arenzon S; Blanco LF; Loureiro R
Int J Dermatol; 2004 Aug; 43(8):568-70. PubMed ID: 15304178
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
10. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.
Amara S; Dezube BJ; Cooley TP; Pantanowitz L; Aboulafia DM
Clin Infect Dis; 2006 Nov; 43(9):1198-205. PubMed ID: 17029142
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
Lascar RM; Gilson RJ; Lopes AR; Bertoletti A; Maini MK
J Infect Dis; 2003 Dec; 188(12):1815-9. PubMed ID: 14673759
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
13. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
Miziara ID; Weber R
Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
[TBL] [Abstract][Full Text] [Related]
14. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of hysterectomy in HIV-seropositive women compared to seronegative women.
Franz J; Jamieson DJ; Randall H; Spann C
Infect Dis Obstet Gynecol; 2005 Sep; 13(3):167-9. PubMed ID: 16126502
[TBL] [Abstract][Full Text] [Related]
17. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
18. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors.
Luder E; Godfrey E; Godbold J; Simpson DM
J Am Diet Assoc; 1995 Jun; 95(6):655-60. PubMed ID: 7759740
[TBL] [Abstract][Full Text] [Related]
19. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
Jain MK; Opio CK; Osuagwu CC; Pillai R; Keiser P; Lee WM
Clin Infect Dis; 2007 Apr; 44(7):996-1000. PubMed ID: 17342656
[TBL] [Abstract][Full Text] [Related]
20. Mode of HIV transmission associated with risk of oral lesions in HIV-infected subjects in Thailand.
Nittayananta W; Chanowanna N; Winn T
J Oral Pathol Med; 2010 Feb; 39(2):195-200. PubMed ID: 20002981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
